Royal Bank of Canada’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Royal Bank of Canada’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,234	Closed	-$12K	–	6952
2016 Q3	$12K	Sell	3,234 -476	-13%	-$2.17K	﹤0.01%	5744
2016 Q2	$19K	Buy	3,710 +558	+18%	+$3.18K	﹤0.01%	5536
2016 Q1	$15K	Sell	3,152 -5,284	-63%	-$23.2K	﹤0.01%	5604
2015 Q4	$39K	Buy	8,436 +5,776	+217%	+$25K	﹤0.01%	5443
2015 Q3	$10K	Sell	2,660 -1,825	-41%	-$12.7K	﹤0.01%	5910
2015 Q2	$38K	Sell	4,485 -2,012	-31%	-$20K	﹤0.01%	5383
2015 Q1	$59K	Buy	6,497 +2,197	+51%	+$27.6K	﹤0.01%	4895
2014 Q4	$61K	Buy	+4,300	New	+$62.4K	﹤0.01%	4970

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royal Bank of Canada's CPHR Position: Q4 2016 in Review

Royal Bank of Canada sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 3,234 shares — an estimated $12K sold.

Royal Bank of Canada first reported a position in CPHR in Q4 2014 and held it in 8 quarters. The position peaked at $61K in Q4 2014. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Royal Bank of Canada reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Royal Bank of Canada sold 3,234 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $12K.
Royal Bank of Canada first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
Royal Bank of Canada's Cipher Pharmaceuticals Inc. position peaked at $61K in Q4 2014.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Royal Bank of Canada's 13F filing for Q4 2016, filed 14 Feb 2017.